ACADIA Pharmaceuticals Inc.
ACAD
$25.13
-$0.32-1.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.67M | 18.99M | 143.74M | 32.77M | 33.39M |
| Total Depreciation and Amortization | 2.94M | 2.95M | 5.21M | 2.57M | 2.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.80M | 9.26M | -138.88M | 23.42M | 13.73M |
| Change in Net Operating Assets | 21.55M | -10.88M | 30.31M | 4.49M | -24.68M |
| Cash from Operations | 63.96M | 20.32M | 40.38M | 63.25M | 25.01M |
| Capital Expenditure | -297.00K | -- | -453.00K | -70.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 146.52M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.00M | -124.05M | -23.91M | -82.39M | -56.19M |
| Cash from Investing | -43.29M | -124.05M | 122.15M | -82.46M | -56.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.96M | 1.84M | 1.97M | 268.00K | 3.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.96M | 1.84M | 1.97M | 268.00K | 3.57M |
| Foreign Exchange rate Adjustments | 24.00K | -5.00K | -60.00K | -42.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.64M | -101.89M | 164.44M | -18.99M | -27.61M |